Literature DB >> 28601286

Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies.

E K Mathey1, N Garg2, S B Park2, T Nguyen2, S Baker3, N Yuki4, C Yiannikas5, C S Lin6, J M Spies7, R Ghaoui8, M H Barnett2, S Vucic9, J D Pollard2, M C Kiernan2.   

Abstract

Autoantibodies to nodal/paranodal proteins have been reported in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) and multifocal motor neuropathy (MMN). To determine the frequency of anti-paranodal antibodies in our cohort of CIDP patients and to validate the presence anti-nodal antibodies in MMN, sera were screened for IgG against human neurofascin 155, contactin-1, neurofascin 186 and gliomedin using ELISA. In CIDP patients, 7% were anti-NF155 IgG4 positive and 7% were anti-CNTN1 IgG4 positive. Positive results were confirmed using cell based assays and indirect immunofluorescence on teased nerve fibres. We did not detect IgG autoantibodies against these nodal/paranodal antigens in MMN patients.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoantibody; Chronic inflammatory demyelinating polyneuropathy; Contactin; Gliomedin; Multifocal motor neuropathy; Neurofascin

Mesh:

Substances:

Year:  2017        PMID: 28601286     DOI: 10.1016/j.jneuroim.2017.05.002

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  15 in total

1.  From PNS to CNS: characteristics of anti-neurofascin 186 neuropathy in 16 cases.

Authors:  Chong Xie; Ze Wang; Nan Zhao; Desheng Zhu; Xiajun Zhou; Jie Ding; Yifan Wu; Haojun Yu; Yangtai Guan
Journal:  Neurol Sci       Date:  2021-03-15       Impact factor: 3.307

Review 2.  Diagnostic insights into chronic-inflammatory demyelinating polyneuropathies.

Authors:  Johannes J Roggenbuck; Joseph Boucraut; Emilien Delmont; Karsten Conrad; Dirk Roggenbuck
Journal:  Ann Transl Med       Date:  2018-09

3.  Peripheral neuropathies: Subcutaneous immunoglobulin - the future of CIDP treatment?

Authors:  Benjamin R Wakerley; Nobuhiro Yuki
Journal:  Nat Rev Neurol       Date:  2018-01-12       Impact factor: 42.937

Review 4.  Nodes of Ranvier during development and repair in the CNS.

Authors:  Catherine Lubetzki; Nathalie Sol-Foulon; Anne Desmazières
Journal:  Nat Rev Neurol       Date:  2020-07-10       Impact factor: 42.937

Review 5.  Neurofascin antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: from intrinsic genetic background to clinical manifestations.

Authors:  Ze Wang; Xiajun Zhou; Nan Zhao; Chong Xie; Desheng Zhu; Yangtai Guan
Journal:  Neurol Sci       Date:  2021-03-29       Impact factor: 3.307

6.  Frequency and clinical correlates of anti-nerve antibodies in a large population of CIDP patients included in the Italian database.

Authors:  Giuseppe Liberatore; Alberto De Lorenzo; Claudia Giannotta; Fiore Manganelli; Massimiliano Filosto; Giuseppe Cosentino; Dario Cocito; Chiara Briani; Andrea Cortese; Raffaella Fazio; Giuseppe Lauria; Angelo Maurizio Clerici; Tiziana Rosso; Girolama Alessandra Marfia; Giovanni Antonini; Guido Cavaletti; Marinella Carpo; Pietro Emiliano Doneddu; Emanuele Spina; Stefano Cotti Piccinelli; Erdita Peci; Luis Querol; Eduardo Nobile-Orazio
Journal:  Neurol Sci       Date:  2022-01-20       Impact factor: 3.307

Review 7.  The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy.

Authors:  Kathleen M Hagen; Shalina S Ousman
Journal:  J Neuroinflammation       Date:  2021-03-22       Impact factor: 8.322

8.  Neurofascin antibodies in autoimmune, genetic, and idiopathic neuropathies.

Authors:  Elisabeth Burnor; Li Yang; Hao Zhou; Kristina R Patterson; Colin Quinn; Mary M Reilly; Alexander M Rossor; Steven S Scherer; Eric Lancaster
Journal:  Neurology       Date:  2017-11-29       Impact factor: 9.910

Review 9.  A New Classification System for IgG4 Autoantibodies.

Authors:  Inga Koneczny
Journal:  Front Immunol       Date:  2018-02-12       Impact factor: 7.561

Review 10.  Autoantibodies Against the Node of Ranvier in Seropositive Chronic Inflammatory Demyelinating Polyneuropathy: Diagnostic, Pathogenic, and Therapeutic Relevance.

Authors:  Atay Vural; Kathrin Doppler; Edgar Meinl
Journal:  Front Immunol       Date:  2018-05-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.